Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease

Open access
Zhang, Si, Zhao, Jiehao, Zhang, Yuhu, Zhang, Yun, Cai, Fang, Wang, Lijuan, Song, Weihong · 2019 · Alzheimer's Research & Therapy

Abstract

Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine. Chronic inflammation induced by amyloid β proteins (Aβ) is one prominent neuropathological feature in Alzheimer’s disease (AD) brain. Elisa, Western blot, and immunohistochemical staining analysis were performed to examine the level of MIF protein in CSF and brain tissues. MTT and LDH assays were used to examine the neurotoxicity, and the Morris Water Maze test was performed to examine the cognitive function in the MIF +/− /APP23 transgenic mice. MIF expression was upregulated in the brain of AD patients and AD model mice. Elevated MIF concentration was detected in the cerebrospinal fluid of AD patients but not in that of the patients suffering from mild cognitive impairment and vascular dementia. Reduced MIF expression impaired learning and memory in the AD model mice. MIF expression largely associates with Aβ deposits and microglia. The binding assay revealed a direct association between MIF and Aβ oligomers. Neurons instead of glial cells were responsible for the secretion of MIF upon stimulation by Aβ oligomers. In addition, overexpression of MIF significantly protected neuronal cells from Aβ-induced cytotoxicity. Our study suggests that neuronal secretion of MIF may serve as a defense mechanism to compensate for declined cognitive function in AD, and increased MIF level could be a potential AD biomarker.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13195-019-0508-x

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Upregulation of MIF in AD patients and AD model mice. a Human brain tissues obtained from Columbia University were lysed in RIPA-DOC buffer, and an equal amount of protein was resolved on a 12% tris-tricine gel. MIF was detected by anti-MIF antibody, and β-actin was detected by the β-actin antibody. b Quantification of (A). Values were expressed as mean ± SEM, n = 5. *p < 0.05 by Student’s t test. c Concentrations of MIF in CSF collected from patients with MCI, AD, and VD, and control subjects were measured by ELISA. Values were expressed as mean ± SEM, n = 30 for control, 28 for AD, 10 for MCI, and 17 for VD. *p < 0.05 by one-way ANOVA with Newman-Keuls post hoc tests compared to control. #p < 0.05 by one-way ANOVA with Newman-Keuls post hoc tests compared to AD. d APP23/PS45 double transgenic mice and the wildtype controls were euthanized at the ages of 2 and 3 months. Half of the brain was fixed and sectioned for plaque assessment, and the other half was used for MIF expression evaluation. Thioflavin S (a, b) and 4G8 (c, d) were used to stained representative brain sections for plaque detection. Arrows point to neuritic plaques. e Brain tissues were lysed in RIPA-DOC buffer, and an equal amount of protein was resolved on a 12% tris-tricine gel. MIF was detected by anti-MIF antibody, and β-actin was detected by β-actin antibody serving as the loading control. The ratio of MIF to β-actin was normalized to wildtype mice. Values were expressed as mean ± SEM, n = 4~8 for wildtype mice and 4~10 for APP23/PS45 mice. p > 0.05 by Student’s t tests. (I) *p < 0.05 by Student’s t tests
Fig. 1 Upregulation of MIF in AD patients and AD model mice. a Human brain tissues obtained from Columbia University were lysed in RIPA-DOC buffer, and an equal amount of protein was resolved on a 12% tris-tricine gel. MIF was detected by anti-MIF antibody, and β-actin was detected by the β-actin antibody. b Quantification of (A). Values were expressed as mean ± SEM, n = 5. *p < 0.05 by Student’s t test. c Concentrations of MIF in CSF collected from patients with MCI, AD, and VD, and control subjects were measured by ELISA. Values were expressed as mean ± SEM, n = 30 for control, 28 for AD, 10 for MCI, and 17 for VD. *p < 0.05 by one-way ANOVA with Newman-Keuls post hoc tests compared to control. #p < 0.05 by one-way ANOVA with Newman-Keuls post hoc tests compared to AD. d APP23/PS45 double transgenic mice and the wildtype controls were euthanized at the ages of 2 and 3 months. Half of the brain was fixed and sectioned for plaque assessment, and the other half was used for MIF expression evaluation. Thioflavin S (a, b) and 4G8 (c, d) were used to stained representative brain sections for plaque detection. Arrows point to neuritic plaques. e Brain tissues were lysed in RIPA-DOC buffer, and an equal amount of protein was resolved on a 12% tris-tricine gel. MIF was detected by anti-MIF antibody, and β-actin was detected by β-actin antibody serving as the loading control. The ratio of MIF to β-actin was normalized to wildtype mice. Values were expressed as mean ± SEM, n = 4~8 for wildtype mice and 4~10 for APP23/PS45 mice. p > 0.05 by Student’s t tests. (I) *p < 0.05 by Student’s t testsCC BY · PubMed Central
Fig. 2 Increased MIF secretion protects neuronal cells from Aβ-induced neurotoxicity. Cells were seeded on seeded onto 96-well plates and cultured 24 h prior to treatment. Aβ treatment was achieved by adding medium diluted Aβ1-42 oligomer stock solution (100 μM in sterile PBS) at the final concentration of 10 μM or 50 μM. LPS at the concentration of 100 ng/mL was used as a positive control for MIF secretion. Sixteen hours after treatment, the culture medium was collected and centrifuged prior to analysis. Media collected from RAW 264.7 (a), BV-2 (b), and SHSY-5Y (c) cell lines were measured for MIF concentrations by ELISA. Values represent mean ± SEM, n = 4. *p < 0.05 relative to controls by one-way ANOVA with Newman-Keuls post hoc tests. #p < 0.05 relative to LPS by one-way ANOVA with Newman-Keuls post hoc tests. d The same batch of media from SHSY-5Y cells were subjected to LDH assay to evaluate the cell membrane integrity. Values represent mean ± SEM, n = 4. *p < 0.05 relative to controls by one-way ANOVA with Newman-Keuls post hoc tests. e SH-SY5Y and SYMS cell lines were subjected to Aβ oligomer treatment at the final concentration of 50 μM. After 24-h treatment, cell viability was assessed by MTS assays. Values represent mean ± SEM, n = 3. *p < 0.05 relative to controls by two-way ANOVA with Bonferroni’s multiple comparison test
Fig. 2 Increased MIF secretion protects neuronal cells from Aβ-induced neurotoxicity. Cells were seeded on seeded onto 96-well plates and cultured 24 h prior to treatment. Aβ treatment was achieved by adding medium diluted Aβ1-42 oligomer stock solution (100 μM in sterile PBS) at the final concentration of 10 μM or 50 μM. LPS at the concentration of 100 ng/mL was used as a positive control for MIF secretion. Sixteen hours after treatment, the culture medium was collected and centrifuged prior to analysis. Media collected from RAW 264.7 (a), BV-2 (b), and SHSY-5Y (c) cell lines were measured for MIF concentrations by ELISA. Values represent mean ± SEM, n = 4. *p < 0.05 relative to controls by one-way ANOVA with Newman-Keuls post hoc tests. #p < 0.05 relative to LPS by one-way ANOVA with Newman-Keuls post hoc tests. d The same batch of media from SHSY-5Y cells were subjected to LDH assay to evaluate the cell membrane integrity. Values represent mean ± SEM, n = 4. *p < 0.05 relative to controls by one-way ANOVA with Newman-Keuls post hoc tests. e SH-SY5Y and SYMS cell lines were subjected to Aβ oligomer treatment at the final concentration of 50 μM. After 24-h treatment, cell viability was assessed by MTS assays. Values represent mean ± SEM, n = 3. *p < 0.05 relative to controls by two-way ANOVA with Bonferroni’s multiple comparison testCC BY · PubMed Central
Fig. 3 MIF deficiency affects cognitive functions in the AD model mice. APP23/MIF+/− and APP23 mice (APP/MIF+/− and APP, respectively) at the age of 12 to 13 months were subjected to the Morris water maze test. a During the first day of visible platform tests, the APP23/MIF+/− and APP23 mice exhibited a similar latency to escape onto the visible platform. P > 0.05 by Student’s t test. b APP23/MIF+/− and APP23 mice had similar swimming distances before escaping onto the visible platform. P > 0.05 by Student’s t test. c In hidden platform tests, APP23/MIF+/− mice showed a longer latency to escape on to the hidden platform on the 5th day. *p < 0.05 by two-way ANOVA with Bonferroni post hoc tests. d APP23/MIF+/− mice had a shorter swimming length before escaping onto the hidden platform on the 5th day. *P < 0.05 by two-way ANOVA with Bonferroni post hoc tests. e On the last day of the trial, APP23/MIF+/− showed a significantly lower number of passing times through the location of the platform than APP23 mice. P < 0.05 by Student’s t test
Fig. 3 MIF deficiency affects cognitive functions in the AD model mice. APP23/MIF+/− and APP23 mice (APP/MIF+/− and APP, respectively) at the age of 12 to 13 months were subjected to the Morris water maze test. a During the first day of visible platform tests, the APP23/MIF+/− and APP23 mice exhibited a similar latency to escape onto the visible platform. P > 0.05 by Student’s t test. b APP23/MIF+/− and APP23 mice had similar swimming distances before escaping onto the visible platform. P > 0.05 by Student’s t test. c In hidden platform tests, APP23/MIF+/− mice showed a longer latency to escape on to the hidden platform on the 5th day. *p < 0.05 by two-way ANOVA with Bonferroni post hoc tests. d APP23/MIF+/− mice had a shorter swimming length before escaping onto the hidden platform on the 5th day. *P < 0.05 by two-way ANOVA with Bonferroni post hoc tests. e On the last day of the trial, APP23/MIF+/− showed a significantly lower number of passing times through the location of the platform than APP23 mice. P < 0.05 by Student’s t testCC BY · PubMed Central
Fig. 4 Colocalization of MIF and amyloid plaques in APP/PS mice. A, B Fixed brains were prepared for paraffin-embedded sectioning at 5 μm thickness. MIF was detected by anti-MIF antibody and visualized by ABC and DBA methods. Nuclei were stained by hematoxylin. The sections were observed under traditional microscopy. Arrows point to plaques associated MIF expression, which resembles the expression pattern of Aβ plaques. Scale bar, 100 μm. C Fixed brains were dehydrated in 30% sucrose solution and embedded in O.C.T. for cryosectioning at 30 μm thickness. MIF was detected by polyclonal MIF antibody, and Alexa 488-labeled secondary antibody, and Aβ plaques were detected by monoclonal 4G8 antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrowspoint to colocalization of MIF and plaques. Arrow heads point to MIF expression cells. Scale bar, 100 μm in B, and 25 μm in inserts and C
Fig. 4 Colocalization of MIF and amyloid plaques in APP/PS mice. A, B Fixed brains were prepared for paraffin-embedded sectioning at 5 μm thickness. MIF was detected by anti-MIF antibody and visualized by ABC and DBA methods. Nuclei were stained by hematoxylin. The sections were observed under traditional microscopy. Arrows point to plaques associated MIF expression, which resembles the expression pattern of Aβ plaques. Scale bar, 100 μm. C Fixed brains were dehydrated in 30% sucrose solution and embedded in O.C.T. for cryosectioning at 30 μm thickness. MIF was detected by polyclonal MIF antibody, and Alexa 488-labeled secondary antibody, and Aβ plaques were detected by monoclonal 4G8 antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrowspoint to colocalization of MIF and plaques. Arrow heads point to MIF expression cells. Scale bar, 100 μm in B, and 25 μm in inserts and CCC BY · PubMed Central
Fig. 5 MIF expression overlaps but is not restricted in the vicinity microglia and astrocytes. Fixed brains were dehydrated in 30% sucrose solution and embedded in O.C.T. for cryosectioning at 20 μm thickness. a MIF was detected by polyclonal MIF antibody and Alexa 488-labeled secondary antibody, and active astrocytes were detected by monoclonal GFAP antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrows point to GFAP-positive cells. Arrowheads point to possible MIF expressing cells. Scale bar, 200 μm and 50 μm in inserts. b Neuritic plaques were detected by monoclonal 4G8 antibody and Alexa 488-labeled secondary antibody, and microglia were detected by polyclonal Iba-1 antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrowheads point to possible MIF expressing cells. Scale bar, 50 μm
Fig. 5 MIF expression overlaps but is not restricted in the vicinity microglia and astrocytes. Fixed brains were dehydrated in 30% sucrose solution and embedded in O.C.T. for cryosectioning at 20 μm thickness. a MIF was detected by polyclonal MIF antibody and Alexa 488-labeled secondary antibody, and active astrocytes were detected by monoclonal GFAP antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrows point to GFAP-positive cells. Arrowheads point to possible MIF expressing cells. Scale bar, 200 μm and 50 μm in inserts. b Neuritic plaques were detected by monoclonal 4G8 antibody and Alexa 488-labeled secondary antibody, and microglia were detected by polyclonal Iba-1 antibody and Alexa 594-labeled secondary antibody. Nuclei were stained with DAPI, and brain sections were observed under fluorescent microscopy. Arrowheads point to possible MIF expressing cells. Scale bar, 50 μmCC BY · PubMed Central
Fig. 6 MIF interacts with Aβ oligomers. a 0.2 nmol of Aβ oligomers and 0.1 nmol of purified GFP protein were spot on a nitrocellulose membrane, and the membrane was incubation with mixed proteins of recombinant hMIF and purified GFP at the concentration of approximated 5 μM at 4 °C for overnight. The membrane was then subjected to immunoblotting to detect MIF and GFP by a monoclonal anti-MIF antibody and a polyclonal anti-GFP antibody, respectively. The red channel detects IR-dye-labeled goat anti-rabbit antibody, and the green channel detects IR-dye-labeled goat anti-mouse antibody. b Brains from 4-month-old APP23/PS45 and wildtype (as controls) mice were homogenized in 5x PBS with 0.5% Triton-100 (v/w) and centrifuge at 16,000×g at 4 °C for 15 min. The supernatants were collected and subjected to ultracentrifugation at 100,000×g for 1 h at 4 °C, and the second supernatants were collected and labeled as S′. Homogenates from each layer were further dissolved in RIPA-DOC buffer followed by brief sonication. The same amount of protein was loaded on 16% and 12% Tris-tricine SDS PAGE gels for Aβ and MIF separation, respectively. Aβ was detected by a 6E10 antibody, MIF was detected by anti-MIF antibody, CTFs were detected by a C20 antibody to confirm the expression of the transgene, and β-actin was detected by β-actin antibody serving as the loading control. S′, supernatant after ultracentrifugation; P1, pellet 1; P2 pellet 2. c Quantification of the level of MIF protein from b. Values represent mean ± SEM, n = 3. *P < 0.05 by Student’s t test
Fig. 6 MIF interacts with Aβ oligomers. a 0.2 nmol of Aβ oligomers and 0.1 nmol of purified GFP protein were spot on a nitrocellulose membrane, and the membrane was incubation with mixed proteins of recombinant hMIF and purified GFP at the concentration of approximated 5 μM at 4 °C for overnight. The membrane was then subjected to immunoblotting to detect MIF and GFP by a monoclonal anti-MIF antibody and a polyclonal anti-GFP antibody, respectively. The red channel detects IR-dye-labeled goat anti-rabbit antibody, and the green channel detects IR-dye-labeled goat anti-mouse antibody. b Brains from 4-month-old APP23/PS45 and wildtype (as controls) mice were homogenized in 5x PBS with 0.5% Triton-100 (v/w) and centrifuge at 16,000×g at 4 °C for 15 min. The supernatants were collected and subjected to ultracentrifugation at 100,000×g for 1 h at 4 °C, and the second supernatants were collected and labeled as S′. Homogenates from each layer were further dissolved in RIPA-DOC buffer followed by brief sonication. The same amount of protein was loaded on 16% and 12% Tris-tricine SDS PAGE gels for Aβ and MIF separation, respectively. Aβ was detected by a 6E10 antibody, MIF was detected by anti-MIF antibody, CTFs were detected by a C20 antibody to confirm the expression of the transgene, and β-actin was detected by β-actin antibody serving as the loading control. S′, supernatant after ultracentrifugation; P1, pellet 1; P2 pellet 2. c Quantification of the level of MIF protein from b. Values represent mean ± SEM, n = 3. *P < 0.05 by Student’s t testCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 94

Metadata

Authors
Zhang, S., Zhao, J., Zhang, Y., Zhang, Y., Cai, F., Wang, L., & Song, W.
Affiliations
  • University of British Columbia (CA)
  • Guangdong General Hospital (CN)
Corresponding author
  • Wang, Lijuan
  • Song, Weihong
Venue
Alzheimer's Research & Therapy
Published
2019-06-07
Volume
11
Issue
1
Pages
54-54
ISSN
1758-9193 (ISSN-L)
OpenAlex
W2948651404
Cited by
73
References
45
Citations by year
2026: 4 · 2025: 14 · 2024: 17 · 2023: 10 · 2022: 11 · 2021: 8 · 2020: 7 · 2019: 2
FWCI
4.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Alzheimer s Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • cIRcle (University of British Columbia) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Open Collections
Funders
Canadian Institutes of Health Research (MOP-142487)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
Keywords
macrophage migration inhibitory factor, Alzheimer's disease, amyloid-beta oligomers, cerebrospinal fluid biomarkers, neuroinflammation, APP23 transgenic mice, learning and memory impairment, microglia, mild cognitive impairment, vascular dementia
MeSH terms
Adult, Aged, Alzheimer Disease, Animals, Brain, Female, Humans, Macrophage Migration-Inhibitory Factors, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Biomarkers, Up-Regulation, Maze Learning, Intramolecular Oxidoreductases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease. https://app.cochat.ai/papers/10.1186/s13195-019-0508-x
The paper
Zhang, S., Zhao, J., Zhang, Y., Zhang, Y., Cai, F., Wang, L., & Song, W. (2019). Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-019-0508-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.